Blood center case studies
"I think overall the IMPACT Program has helped in a couple of areas. It helped us to realize that how we deploy machines in the region has a significant impact on the total overall cost of a blood drive. And that the support we received from Haemonetics was probably just as vital as the actual program itself.”
William Henry, Executive Director, 06.2011 View document
"This program helped us control and decrease our cost per collection. By utilizing the data collected we have identified the most cost effective mobiles with the right products. This has allowed us to attract the right donors and produce quality products in a cost-effective manner.”
Connie Morris, Executive Director, 08.2011 View document
"The IMPACT Program has allowed us to drill down from information that we had… And having that ability, and the technical and consultative services from Haemonetics, has really allowed us to impact our costs significantly."
Stacy Sime, President and CEO, 04.2011 View document
"Our Haemonetics trainers were top-notch and very easy to work with, while at the same time, they held us to a high level of achievement. I especially appreciated the fact that the focus was not on memorizing mathematical calculations, but rather on how to understand and apply the Six Sigma tools in a highly practical manner. Haemonetics Corporation’s many years of experience in blood collection meant that we never had to explain the subtleties associated with our particular industry."
Gregg Booth, Division Director, Laboratories, 04.2009 View document
After partnering with Haemonetics to implement Six Sigma methodology to improve internal processes, MVRBC achieved an annual savings of more than $700,000 and $420,000 in new revenues, increased their blood supply, and reduced platelet outdating. View document
Through the use of Haemonetics’ consulting services, a large blood center was able to increase their 2RBC collections, boost growth in O- red cell products, improve their donor conversion practices, and expand market penetration. View document
The ACP 215 system is the integral component of the US DoD’s new Strategic Frozen Blood Program that has enabled it to achieve significant improvements and successful results in theaters of operation across the globe.
View document
back to top
Hospital case studies
"Haemonetics’ solutions helped us develop an effective autologous blood management program. The OrthoPAT system is a powerful tool that supports us to provide safe and secure medical care benefits to our patients in joint reconstructive surgery."
Kazuo Hirakawa, Hospital Director, and Takeshi Kaneko, Department of Orthopedics
Shonan Kamakura Joint Reconstruction Center’s, Japan, 04.2010
"We will continue to use the OrthoPAT System on THA and TKA cases as part of our blood management program. We believe Haemonetics’ solution has had an impact on the number of patients needing transfusions, by reducing the number of allogeneic transfusions, and thereby increasing safety in orthopedic surgeries."
Takashi Nakamura, Department Lecturer, Toho University Omori Medical Center, Japan 04.2010
"The OrthoPAT system is efficient, cost effective and gives me the confidence to tell patients, ‘I won’t have to give you any blood except your own.’ ”
Stuart Gordon, M.D. Orthopedic Surgeon, 07.2011 View document
"Quite frankly, I was overwhelmed with how much of a difference using the OrthoPAT made. Having the data to back it up really drove the point home and reinforced that what we were seeing in practice was real."
Dr. Steven Jones, Orthopedic Surgeon, 05.20011 View document
"I knew the device was doing some really good things for the patients and the blood bank, but the numbers really backed up what I thought was going on… I haven’t seen another machine out there that does what the OrthoPAT does… it’s just a really good product.”
Damian Loehle, Operating Room Nurse, 07.2011 View document
"I am pleased that the Haemonetics TEG system solves one of our blood management challenges. The TEG system helps us reduce unnecessary blood transfusions, thus helping us provide better care to our patients and economic savings to our hospital."
Dr. Tsou Mei-Yung,
Chief, 04.2009 View document
"We started to use the cardioPAT system on select cases in July 2008. We used it on all valves, resternotomies, circulatory arrest cases, and any other cases with increased potential for post-op bleeding. Through December 2008, we used the cardioPAT system on 52 cases, of which 27 cases were processed. We believe the Haemonetics solution has had an impact on the number of patients needing transfusions and in reducing the number of allogeneic transfusions overall."
John Pieroni,
Perfusion Chief, 04.2009 View document
"With the cooperation of Haemonetics, we changed our blood management program in 2005 to our significant benefit. By eliminating preoperative blood donation and using OrthoPAT and Cell Saver extensively, we achieved a remarkable reduction in homologous blood units—up to 160 units less per year—which works out to about a savings of 50,000 € for the hospital over three years. Our blood management practice will continue in this direction for the future, with Haemonetics as our partner."
Dr. F-J. Unterburger,
Head of Department, 04.2009 View document
"For over 25 years, we have enjoyed an excellent relationship with Haemonetics. During this time we have always been pleased with the company’s devices, disposables and consultation services. Together, Haemonetics solutions and personal contact with the company’s representatives have helped RKU develop an effective and profitable autologous blood management program that has benefited our patients."
Dr. Peter Geiger,
Head of Department of Anesthesiology
and Intensive Care Medicine, 04.2009
View document
back to top